Aerie Pharmaceuticals (United States)

Aerie Pharmaceuticals (United States)

Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Aerie Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

64%


Total
Publications

64


Total Open
Publications

41


Total
Citations

3.1K


Open Access
Percentage

64%


Total
Publications

64


Total Open
Publications

41


Total
Citations

3.1K

Wikipedia

Website

download

Breakdown

22% 34% 8% 36%

Publisher Open

22%

Both

34%

Other Platform Open

8%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

19%OA Journal

OA Journal 19%

7

Hybrid 67%

24

No Guarantees 14%

5

Other Platform Open

Domain 85%

23

Preprint 19%

5

Public 15%

4

Other Internet 11%

3

Institution 4%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
23
Europe PMC
Domain
12
bioRxiv
Preprint
4
Semantic Scholar
Public
3
DOI
Other Internet
2
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
1
RePEc: Research Papers in Economics - RePEc
Preprint
1
Figshare
Public
1
California Digital Library - eScholarship
Other Internet
1
1 / 1

Data updated 7 April 2025

Share

Share

Share